← Safety and Risk of Pharmacotherapy
Papers in Safety and Risk of Pharmacotherapy
Page 3 · newest first
- Experience in Using Antiviral Agents for the Treatment of Novel Coronavirus Infection (COVID-19) in KyrgyzstanSafety and Risk of Pharmacotherapy · 2021
- Cardiotoxic Effects of Yew Tree and Pink Periwinkle AlkaloidsSafety and Risk of Pharmacotherapy · 2021
- Nephrotoxicity Biomarkers: Role and Significance in the Diagnosis of Drug-Induced Kidney InjurySafety and Risk of Pharmacotherapy · 2021
- Investigation of Cytotoxic Effects of Recombinant Human Interferon Lambda-1 and Its Pegylated Form on Human Conjunctival Epithelial CellsSafety and Risk of Pharmacotherapy · 2021
- Drug-Induced Acute Kidney InjurySafety and Risk of Pharmacotherapy · 2021
- Analysis of Adverse Reactions in Elderly Patients Based on Quantitative Methods of Signal DetectionSafety and Risk of Pharmacotherapy · 2021
- Fluoroquinolone-Induced Aortic InjurySafety and Risk of Pharmacotherapy · 2021
- Limits for the Content of Heavy Metals and Arsenic as a Means of Ensuring Safe Use of Herbal Medicinal ProductsSafety and Risk of Pharmacotherapy · 2021
- Possible Causes of and Measures to Minimise Risks of Abscesses Following DTP VaccinationSafety and Risk of Pharmacotherapy · 2021
- Advanced Age as a Risk Factor of Drug-Induced DiseasesSafety and Risk of Pharmacotherapy · 2021
- Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic TreatmentSafety and Risk of Pharmacotherapy · 2021
- Study of the Effect of Polymorphic Markers of the NAT2 Gene on the Risk of Adverse Drug Reactions in Patients with Pulmonary Tuberculosis Who Received Isoniazid and RifampicinSafety and Risk of Pharmacotherapy · 2021
- Effect of Organic Anion Transporters on the Development of Nephrotoxicity in the Context of NSAIDs UseSafety and Risk of Pharmacotherapy · 2020
- Safety of Herbal Medicines: Clinical and Pharmacological AspectsSafety and Risk of Pharmacotherapy · 2020
- Atrial Fibrillation Associated with Anticancer DrugsSafety and Risk of Pharmacotherapy · 2020
- Adverse Oral Reactions Associated with Low Doses of MethotrexateSafety and Risk of Pharmacotherapy · 2020
- Ongoing challenges and future directions of human papillomavirus vaccinationSafety and Risk of Pharmacotherapy · 2020
- Drug-Induced Neutropenia and AgranulocytosisSafety and Risk of Pharmacotherapy · 2020
- Comparative Analysis of International Databases of Adverse Drug ReactionsSafety and Risk of Pharmacotherapy · 2020
- Some Aspects of Drug Induced Nephrotoxicity AssessmentSafety and Risk of Pharmacotherapy · 2020
- Drug-Induced Fatty Liver DiseaseSafety and Risk of Pharmacotherapy · 2020
- Drug-Induced Heart Failure (Part 1: The Urgency of the Problem, the Prevalence, the Effect of Certain Groups of Drugs on the Risk of Development/Progression Heart Failure)Safety and Risk of Pharmacotherapy · 2020
- Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor AgentsSafety and Risk of Pharmacotherapy · 2020
- Coronavirus disease COVID-2019Safety and Risk of Pharmacotherapy · 2020
- Analysis of Safety Issues of Using Statins in Patients with Diabetes and HypothyroidismSafety and Risk of Pharmacotherapy · 2019
- Drug-Induced EosinophiliaSafety and Risk of Pharmacotherapy · 2019
- Topical Issues of Drug Safety, Possibilities of Improving of PharmacovigilanceSafety and Risk of Pharmacotherapy · 2019
- Nanoscale Therapeutic System: Safety Assessment FeaturesSafety and Risk of Pharmacotherapy · 2019
- Opioids and Migraine: Opioid Awareness and Frequency of Use among Turkish MigraineursSafety and Risk of Pharmacotherapy · 2019
- Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacinSafety and Risk of Pharmacotherapy · 2019
- Interferon Beta: Analysis of Information on Adverse Reactions and Evaluation of Possibility of Signal IdentificationSafety and Risk of Pharmacotherapy · 2019
- Literature Monitoring for PharmacovigilanceSafety and Risk of Pharmacotherapy · 2019
- A Review of Cases of Development of Acute Hepatic Insufficiency Due to the Intake of Biologically Active AdditivesSafety and Risk of Pharmacotherapy · 2018
- Pharmacogenetics of Organic Cation TransportersSafety and Risk of Pharmacotherapy · 2018